Regulation

The FDA and CRCG hold a two-day workshop on the generic GLP-1 pathway on 23 and 24 September 2026. The agenda names every point at which two peptides with identical sequences stop being the same medicine.

The FDA published five warning letters to research-peptide sellers on 1 September 2026. All five rest on website review alone, and the agency states directly that research-use-only labelling did not displace the evidence of intended human use.

FDA revised 17 product-specific guidances for generic peptides and withdrew its 2021 synthetic peptide guidance. The five areas it targeted explain why the same amino acid sequence does not guarantee the same drug.

FDA set aside an RUO disclaimer and ruled on the rest of the website instead. Lilly then asked payment processors and carriers to cut off sellers. Together they define how this sector is now assessed.

Tesofensine has no EMA marketing authorisation and is not an EU-scheduled controlled substance — but it remains an unapproved investigational compound. The 2026 regulatory picture, from primary EU records.

There is no single legal status for research compounds in Europe — it depends on the molecule and, above all, on what it is sold and used as. Across the compounds Condor Research supplies, the pattern is consistent: almost none hold an EU medicine authorisation, most are not authorised foods or supplements, and several (the…

Is CJC-1295 legal in Europe? It has never been authorised as a medicine anywhere in the world and is explicitly named on the WADA 2026 Prohibited List. An honest, source-cited look at what its RUO status actually means.

Is ipamorelin legal in Europe? It holds no EMA authorisation, was abandoned after Phase II trials, and is explicitly named on the WADA 2026 Prohibited List. An honest, source-cited look at what ‘legal’ actually means for a compound with no approved human use anywhere in the world.

Is 5-Amino-1MQ legal in Europe? It has no EMA authorisation, no novel-food status, and exists in a genuine regulatory vacuum. An honest, source-cited look at what ‘legal’ really means for this NNMT inhibitor.

Is NAD+ legal in Europe? The honest answer splits along precursor vs coenzyme. NR is an authorised novel food; NMN is not; NAD+ itself is supplied as a research reagent (RUO). Verified EU sources, no legal advice.